News
12h
Zacks Investment Research on MSNBMY vs GSK: Which Biopharma Bigwig Has Better Prospects for Now?
Bristol Myers Squibb (BMY) and GSK PLC (GSK) are among the largest global biopharma companies with broad and diverse ...
Past efforts to collect data and to understand the relationship between minimal residual disease and outcomes will allow help ...
GSK (NYSE:GSK) announced on Monday that the U.S. FDA has granted priority review for its marketing application, aimed at ...
Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the mRNA vaccine technology that was at the forefront of the world's fight ...
NEW YORK, Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GSK plc ("GSK" or the "Company") (NYSE: GSK). Such investors are advised to contact Danielle ...
A phase 2b trial of HMNC Brain Health’s depression drug candidate has missed its primary endpoint. But while the ex-Sanofi molecule failed to move the needle in the pre-specified population ...
We have the answer for The "G" of the pharmaceutical company GSK crossword clue that will help you solve the crossword puzzle you're working on!
Last month, Hengrui Pharmaceuticals announced a blockbuster licensing deal with GSK worth up to USD 12.5 billion, with an upfront payment of USD 500 million. The deal grants GSK the overseas rights to ...
Dr Audrey Stevenson shares highlights from the latest immunization guidance for children and adults.
Although obinutuzumab has not yet received FDA approval in lupus nephritis, findings from a recent survey conducted by Spherix Global Insights indicated increasing use and comfort with this ...
GSK signed a 12-asset licensing deal with Hengrui. Generic erosion on Vyvanse pulled back Takeda. Celltrion plans to buy a large U.S. facility.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results